CRO Service on Regulatory approval
Request for Quotation
Dear All CRO service provider:
Our company, WomenX Biotech Limited has launched a product for non-invasive detection for HPV in menstrual blood. For entering the global market, we are planning obtain FDA, NMPA and CE certifications in the next 15 months. You are invited to submit the quotation and proposal for
FDA (including ISO 13485) NMPA and CE application to WomenX Biotech Limited. Attached
please find RFQ for your reference
RFQ details could be downloaded here:
https://drive.google.com/file/d/1sZbcqvhpWIyTwlxAsiLgeFduHngTb7rO/view?usp=sharing
The submission should be returned by email to clinical@womenx.net
with service details, a line-by-line break down of costs, company profile and client reference,_on or before 28 Nov 2024 by 23:59 (GMT+8). Late submission will not be considered.
RFQ-Interest for Participation
*By submitting this form, you agree our staff will contact you through the information you provided. Your personal information collected and held by us will be used for the clinical study only.
